An individual's nerve cells produce a special chemical called serotonin. It is responsible for sending signals from one nerve ...

Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

This was the first of three planned phase-3 trials of the drug. Neumora aims to offer a new way of treating depression. Unlike most common antidepressants that work by boosting serotonin levels in ...

Purpose: The pharmacology, pharmacokinetics, efficacy, safety, drug interactions ... major depression, duloxetine has achieved remission rates similar to that of existing selective serotonin ...

To treat depression, the tech magnate has said he'd rather use ketamine, a dissociative anesthetic, than traditional antidepressants.

Detailed price information for Bright Minds Biosciences Inc (DRUG-Q) from The Globe and Mail including charting and trades.

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy ... than current tricyclic or selective serotonin reuptake inhibitor drugs can take weeks to elevate mood ...

Discover why psychiatrists are moving beyond single-treatment approaches and how combining therapies could be the key to ...

Studies show psilocybin from mushrooms could revolutionize depression treatment offering hope to millions who don't respond ...

UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment ... laid out its plans to develop the drug known as COMP360, which is a ...